Hazard
462 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all sterility failure recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
CareFusion 213, LLC is recalling PurPrep sterile topical solution due to lack of assurance of sterility and potential product contamination. The affected product is a povidone-iodine and isopropyl alcohol solution distributed nationwide.
Fresenius Medical Care is recalling DELFLEX Dextrose Peritoneal Dialysis Solution bags due to potential leaks from bag perforations that could compromise sterility. Affected patients should contact their healthcare provider immediately.
Harrow Eye LLC is recalling FRESHKOTE Lubricant Eyedrops because the manufacturer cannot guarantee the product remains sterile. Affected lots are 1X68 and 1X69, with an expiration date of 05/31/2027.
Payless Compounders is recalling a compounded semaglutide injectable due to lack of sterility assurance. The recall affects 91 vials distributed in Oregon.
Fagron Compounding Services is recalling 5,140 bags of norepinephrine injectable nationwide due to lack of sterility assurance and a potentially detachable component in the administration port. The affected lots expire between April and July 2026.
Fresenius Kabi USA, LLC is recalling specific batches of 0.9% Sodium Chloride Injection due to lack of assurance of sterility. Patients who have this product should contact their healthcare provider.
Fresenius Kabi USA is recalling a batch of 0.9% Sodium Chloride Injection due to lack of assurance of sterility. The product was distributed nationwide, in Alaska, and Puerto Rico.
Fresenius Kabi recalled specific batches of 0.9% sodium chloride injection because sterility cannot be assured. The affected batches were distributed throughout the United States, Alaska, and Puerto Rico.
Fagron Compounding Services is recalling Vancomycin HCL injectable solutions due to lack of sterility assurance and risk that a blue break-off part could detach from the administration port.
Artificial Tears glycerin eye drops made by Preferred Pharmaceuticals are being recalled due to lack of sterility assurance. The 0.5 oz bottles were distributed nationwide.
K.C. Pharmaceuticals recalls Leader Artificial Tears and related generic brands nationwide due to inability to assure product sterility. Approximately 589,848 bottles across multiple brands and retailers are affected.
Chiesi USA, Inc. is recalling 7,235 vials of CUROSURF (poractant alfa) nationwide due to lack of assurance of sterility. The affected intratracheal injection is used in neonatal care.
Semaglutide injectable vials (lot 240903) are being recalled due to lack of sterility assurance. The product was distributed in Ohio with expiration 9/30/2026.
Medline has recalled certain Nail Kits because the sterile saline wound wash component may not meet required sterility standards. The affected kits were distributed nationwide and internationally.
Medline Industries is recalling Meijer STERILE saline wound wash because the manufacturer may not have met required sterility standards. The recalled product was distributed nationwide in the US and internationally.
Vista Gonio Eye Lubricant is recalled nationwide due to lack of sterility assurance during manufacturing. The product was not made under proper conditions required for eye medications.
Vista Tears polyethylene glycol 400 and propylene glycol 0.3% eye drops are recalled nationwide due to failure to assure sterile manufacturing conditions. Consumers should stop using the product and contact their healthcare provider if they have experienced eye problems.
The FDA has recalled 184,320 containers of BioGlo Fluorescein Sodium Ophthalmic Strips nationwide due to lack of sterility assurance resulting from manufacturing non-compliance. Consumers should stop using the product and consult a healthcare provider.
Medline is recalling sterile saline wound wash products due to potential failure to meet required sterility assurance levels. The products may not be guaranteed sterile for safe wound care.
Medline is recalling 1,640 Nail Kits containing sterile saline wound wash because the manufacturer may not have met minimum sterility assurance levels. The affected kits were distributed nationwide and internationally.
Bio Glo Fluorescein Sodium Ophthalmic Strips are being recalled due to lack of assured sterility and failure to comply with good manufacturing practices.
Vista Hypromellose eye drops have been recalled nationwide due to sterility assurance failures and noncompliance with manufacturing standards. Approximately 17,280 cartons are affected.
Medline is recalling 12,418 surgical convenience kits due to calibration issues with sterilization and packaging equipment that may compromise sterility assurance. No illnesses have been reported.
Medline Industries is recalling 1,496 Convenience Kits due to calibration issues with sterilization and packaging equipment. The calibration defects could compromise the sterility assurance of these surgical instrument kits.
Medline Industries is recalling certain Chest/Breast-LF Convenience Kits due to equipment calibration issues that could compromise sterility assurance during sterilization and packaging. The affected kits were distributed nationwide.